NOVARTIS PHARMA, AG ,   Switzerland

Athenitor®
An antitumour agent, a protein kinase inhibitor
Tablets are dispersible for 2, 3 and 5 mg.
Voltaren®
Non-steroidal anti-inflammatory drug
Solution for intramuscular injection 25 mg / ml.
Desferal®
Complexing agent
Lyophilizate for solution for injection 500 mg.
Xolar
Other means for systemic use in obstructive airways diseases

Lyophilizate for the preparation of a solution for subcutaneous administration, 150 mg, complete with a solvent - water for injection.

Liorasal® Intrathecal
Miorelaxant of central action
The solution for intrathecal administration is 0.05 mg / ml, 0.5 mg / ml, 2 mg / ml.
Lucentis®
means of different groups for use in ophthalmology

Solution for intraocular administration with ranibizumab 10 mg / ml.

  1. To 0.23 ml in a bottle of colorless glass, corked with a rubber stopper, coated with an aluminum cap with a snap-off lid.

By one a vial complete with a needle equipped with a filter to extract the contents from the vial, a syringe, an injection needle along with an instruction for medical application in a cardboard box.

  1. For 0.165 ml of the drug in pre-filled glass syringe, sealed with a rubber stopper with a white polypropylene cover to control the first opening. One by one in advance filled syringe in a blister equipped with a label, along with instructions for medical use in a cardboard box.

Sandimmun®
Immunosuppressive remedy.

Concentrate for the preparation of a solution for infusions of 50 mg / ml, 1 ml in ampoules.

Sandimmun® Neoral®
Immunosuppressive remedy.
Capsules are soft with a dosage of 10, 25 mg, 50 mg and 100 mg.
Sertican®
immunosuppressive agent
Tablets are dispersible 0.1 mg.
Tablets are dispersible 0.25 mg.

Sybri® Brizhaler®
m-holinoblokator

Capsules with powder for inhalation, 50 mcg.


Simulect®
Immunosuppressive means - antibodies monoclonal
Lyophilizate for the preparation of a solution for intravenous administration of 20 mg.
Tacsin®
antitumor agent, protein-tyrosine kinase inhibitor.

Capsules 150 mg and 200 mg.

Toby®
Antibiotic - aminoglycoside.
Solution for inhalation 5 ml
Ultibro® Brizhaler®
Bronchodilator combined (m-holinoblokator + beta2-adrenomimetik selective)

Capsules with powder for inhalation 50 μg + 110 μg.

Fluorescein Novartis
diagnostic tool
A solution for intravenous administration of 100 mg / ml,
Foradyl
bronchodilator - beta2-adrenergic selective
Capsules with powder for inhalation, 12 μg
Foradil Combi
bronchodilating agent combined (β2-adrenomimetic selective + glucocorticosteroid local)

Capsule with powder for inhalation set.

Excelon®
cholinesterase inhibitor
Solution for oral administration 50 ml or 120 ml.
Excelon®
cholinesterase inhibitor
The transdermal therapeutic system is 4.6 mg / 24 h or 9.5 mg / 24 h.
Eksidzhad®
Complexing agent.
Tablets are dispersible 125 mg, 250 mg and 500 mg.